What's happening
This bill limits pharmacy payments and administrative costs for high-cost drugs over $670 to no more than 2.5% of the drug's total cost plus dispensing fees.
Why it matters
Caps total pharmacy payments and administrative costs for very expensive drugs. By setting a strict 2.5% limit on administrative compensation relative to the drug’s price (plus set dispensing fees), the bill aims to prevent disproportionately high markups or middleman fees on drugs costing over $670.
Could lower costs for state Medicaid and potentially for patients. This restriction is likely to reduce what New York State pays through Medicaid for high-cost drugs, potentially freeing up resources for other health services or reducing patient cost-sharing if savings are passed along.
Targets pharmacy benefit management and pricing practices. By tying reimbursement and admin costs directly to the drug price, the bill confronts practices where administrative fees can balloon alongside drug prices, discouraging profiteering as drug costs rise.
May influence pharmacy operations and availability. While aiming to control spending, the cap could impact how pharmacies prioritize stocking or dispensing high-cost drugs, especially if they perceive the capped reimbursement as insufficient to cover actual costs or risks.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Limit Pharmacy High-Cost Drug Payments
Plain English, a few words. Used as the page title.
Sponsors
3 Co-sponsors
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Cap Pharmacy Fees for Costly Drugs
In Senate Committee · Health · Sponsor Diane J. Savino
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
7847
2021-2022 Regular Sessions
IN ASSEMBLY
May 27, 2021
Introduced by M. of A. REYES -- read once and referred to the Committee on Health
AN ACT to amend the social services law, in relation to determining the amount paid to a pharmacy for certain high cost drugs
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Paragraph (b) of subdivision 9 of section 367-a of the social services law is amended by adding a new subparagraph (iv) to read as follows:
(iv) notwithstanding subparagraphs (i) and (ii) of this paragraph and paragraph (e) of this subdivision, if the drug dispensed is a high cost drug and has a national average drug acquisition cost set by the federal center for medicare and medicaid services in excess of six hundred seventy dollars, the actual amount paid to the pharmacy, plus the reasonable administrative costs as determined by the commissioner of health, shall be no more than two and one-half percent of the total cost of such drug, together with any dispensing fee authorized under paragraph (d) of this subdivision.
§ 2. This act shall take effect immediately; provided, however, that the amendments to subdivision 9 of section 367-a of the social services law made by section one of this act shall not affect the expiration of such subdivision and shall be deemed to expire therewith.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD11420-01-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.